NASHVILLE, Tennessee – LGM Pharma attended the CPhI Worldwide 2012 event in Madrid, Spain on October 9-12. The event featured over 29,000 attendees from 133 countries and 2,200 exhibitors. Attendees ranged from the entire spectrum of the pharmaceutical industry, including API manufacturers and biopharmaceutical firms, to contract research organizations (CRO) and contract research and manufacturing service (CRAMS) organizations. LGM Pharma held several face-to-face, highly targeted meetings at the show, to identify business opportunities and cultivate potential partnerships.
CPhI Worldwide is one of the world’s leading pharmaceutical networking events. “CPhI provides an efficient and effective platform to actively do business, and stay informed about the latest industry trends.” explains Mendy Schurder, COO of LGM Pharma, a leading supplier of active pharmaceutical ingredients (APIs) to global pharmaceutical firms, “As a further reflection of growth in the company, we anticipate continued participation in similar trade shows for the drug industry, including the API China Fair, Informex USA and DCAT Week.”
About LGM Pharma
LGM Pharma is a leading supplier of active pharmaceutical ingredients (APIs) to various global pharmaceutical firms involved in the research and development of old and new therapeutic chemical entities. In its commitment to improving health opportunities all over the world, the company has forged partnerships with some of the biggest names in the pharmaceutical industry. Currently, the company supplies over 2,500 active pharmaceutical ingredients to its global clients. Their corporate offices are located in Nashville, Tennessee.